Wuhan Desheng Biochemical Technology Co., Ltd

The selection of biological buffering agents directly affects the stability of experiments and products in cell culture, cell cryopreservation, and in vitro diagnostic (IVD) reagent preparation. HEPES and Tris are two types of high-frequency buffer systems that are not interchangeable, but have their own applicable boundaries. This article starts from the molecular structure and physicochemical properties, and summarizes the differences and typical scenarios between the two. 1.Why buffering agents are worth pondering The sensitivity of cells to pH is often underestimated. The optimal environment for mammalian cells is usually pH 7.2-7.4, and a deviation of 0.2 units may affect the adhesion state, metabolic rate, and surface marker expression. The responsibility of buffering agents is to stabilize this range. The traditional bicarbonate (NaHCO3/CO ₂) system has low cost and strong physiological relevance, but relies on a 5% CO ₂ incubator. Once cells leave the incubator - through liquid exchange, washing, sorting, transportation, and pre freezing treatment - the release of CO ₂ will cause a rapid increase in pH. This is precisely why Good's buffers such as HEPES and MOPS enter the cell culture system. 2.The molecular structure determines their 'personality' HEPES (4-hydroxyethylpiperazine ethanesulfonic acid) is a zwitterionic buffering agent that contains both a basic piperazine ring and an acidic sulfonic acid group. Its net charge is close to neutral at physiological pH. Its pKa is about 7.5 (25 ℃), with an effective buffering range of 6.8-8.2, which precisely covers the physiological range of cell growth. Tris (trihydroxymethylaminomethane) is a primary amine weak base with a pKa of approximately 8.06 (25 ℃) and an effective buffering range of 7.0-9.0. It has a simple structure and controllable cost, and is one of the buffering agents with a large dosage in molecular biology laboratories. The structural differences directly lead to the following four quantifiable practical differences. 3.Differences in Four Dimensions 3.1  Temperature stability. The pKa temperature coefficient of HEPES is about -0.014/℃, and Tris is about -0.028 to -0.031/℃, which is about twice that of the former. In practical operation, the performance is as follows: adjust Tris buffer to pH 8.0 at 25 ℃, and after cooling to 4 ℃ in the cold chamber, the measured pH will significantly increase, and then decrease again at 37 ℃; However, HEPES has a pKa of approximately 7.3-7.4 at 37 ℃, still closely following the physiological range. Cell experiments that require cross temperature manipulation are particularly sensitive to this. 3.2  Membrane permeability and metal ion binding. HEPES has strong polarity and is not easily able to penetrate the cell membrane; The binding ability with divalent metal ions such as Mg ² ⁺ and Ca ² ⁺ is very low, and it does not seize the cofactors required for enzyme reactions. Tris, as a primary amine, can form complexes with some metal ions and may also react with aldehydes and some crosslinking agents. Additional verification is required when metal dependent enzymes or specific labeling systems are involved. 3.3  Testing system compatibility. HEPES has limited impact on biochemical reactions, with extremely low absorption of visible and ultraviolet light, and minimal interference in spectrophotometric and enzymatic assays. It is not without its shortcomings - free radicals may be generated under light exposure, photosensitive cell lines and redox related research require light avoidance operations, and raw material costs are also higher than Tris. Tris may cause interference in some protein quantification methods, and the tolerance limits of different detection kit formulations vary greatly. It is recommended to verify the specific method before use. 3.4   Dependence on CO ₂. Both belong to non bicarbonate systems and can be separated from the incubator to maintain pH. This is also the core reason why they supplement bicarbonate systems in cell washing solutions, sorting buffers, and transport preservation solutions. 4.Scene determines selection Cell culture and cell processing: Serum free culture medium, cell cryopreservation solution, washing solution, flow cytometry buffer, as well as in vitro operation of cell therapy products such as CAR-T and stem cells, the physiological pH matching and low membrane permeability of HEPES are more compatible. Molecular diagnosis and protein research: Nucleic acid extraction and amplification buffer, electrophoresis buffer system (TAE/TBE), SDS-PAGE, protein purification, Tris buffer range and cost advantages are more prominent. IVD reagents: Tris is often used as the main buffering agent in systems such as chemiluminescence and enzyme-linked immunosorbent assay dilutions; When the reagent system is sensitive to metal ions or requires stricter pH stability, HEPES has an advantage. In reality, the two often coexist in the same process - HEPES for upstream cell processing and Tris for downstream detection. The premise of being "superior" is always "in what context". 5.After selection: Consistency of raw materials is the long-term variable The fluctuation of reagent performance often comes not from the formula, but from the differences in raw material batches. The purity, impurity spectrum, moisture, and residual metal ions of the buffer will all be transmitted to the stability of the final product. Hubei Xindesheng Material Technology Co., Ltd. (formerly known as Wuhan Desheng Biochemical Technology Co., Ltd. established in 2005) has long been dedicated to the research and production of biological buffering agents and related fine chemicals. Its product system covers more than 50 models such as Tris, HEPES, MOPS, Bicine, CAPS, etc., and can provide supply and index customization from gram to ton levels. The company's headquarters is located in Guanggu United Science and Technology City, Gedian Development Zone, Ezhou, Hubei Province. It has two R&D and production bases in Gedian and Huanggang (70 acres), with an annual production capacity of 5000 tons for all categories. Its products are used in IVD in vitro diagnostics, biomedicine, and daily chemical industries. HEPES and Tris are not a binary choice. By understanding the four underlying parameters of pKa, temperature coefficient, membrane permeability, and compatibility, and comparing them with one's own process temperature, cell type, and detection system, the answer usually emerges on its own. For the raw material side, regardless of which one is chosen, stable supply and consistent batch quality are the prerequisites for the formula to be stably reproduced.

In discussions on cell culture, HEPES is often described as "low toxicity". This statement is correct in direction, but it can easily be misinterpreted as "no upper limit" - in actual work, if the three things of concentration, light, and osmotic pressure are not handled properly, the experimental results will still deviate. 1.Widely cited safety intervals The general recommendation given by Desheng is 10-25 mM, which can be used to supplement buffering capacity when operating outside the incubator. The common formulas for commercially available culture media also fall within this range: for example, DMEM/F-12 often contains 15mM, and DMEM often contains 25mM. The reason why this interval is repeatedly quoted is that it satisfies two conditions simultaneously: the buffer capacity is sufficient to cope with pH fluctuations in conventional operations, while the additional osmotic pressure introduced is still within the acceptable range of the cell. 2.Where does the upper limit of concentration come from There are three main reasons why the concentration cannot be infinitely increased. 1. Osmotic pressure. This is the most direct one. Adding HEPES in the form of free acid, alkali, or sodium salt will increase the osmotic pressure of the solution. The tolerance range of most mammalian cells is between 260-350mOsm/kg. The higher the concentration, the more amount needs to be deducted from NaCl or NaHCO3, and the less room for adjusting the formula. 2. Phototoxicity. This is an easily overlooked point. HEPES can generate reactive oxygen species such as hydrogen peroxide under visible light irradiation, especially in the presence of riboflavin in the culture medium. Therefore, the culture medium containing HEPES needs to be stored and handled away from light; For experiments with long-term light imaging, it is suggested to use MOPS system or adopt methods such as reducing light intensity and adding reactive oxygen species scavengers. 3. Direct effects of high concentration. Technical data suggests that when the concentration exceeds 40 mM, some cell lines may experience inhibited proliferation and morphological changes. It should be clarified that there are significant cell line differences in the sensitivity of such effects, and not all cells are the same, nor is there a universal "toxicity threshold". 3.Why does the conclusion of 'toxicity' always seem vague When consulting relevant materials, it can be found that the conclusions about the cytotoxicity of HEPES are often inconsistent. This is not a matter of data quality, but rather a significant difference in the experimental conditions themselves: Different cell types: The tolerance of tumor cell lines to primary cells and stem cells can differ significantly Different lighting conditions: exposure time and light intensity directly affect the generation of reactive oxygen species Different components of the culture medium: the content of photosensitive components such as riboflavin is a key variable Different exposure durations: short-term operations of a few hours versus long-term cultivation of several days, conclusions cannot be directly compared Different endpoints are determined: proliferation inhibition, morphological changes, apoptosis, metabolic activity, measuring different things Therefore, when seeing the conclusion that "a certain concentration is toxic to a certain cell", one should first confirm whether its experimental conditions are comparable to their own system. 4.Determine the working concentration for one's own cells Instead of using other people's numbers, a more reliable approach is to conduct a small-scale gradient experiment: Set gradients: 0, 10, 15, 20, 25mM (if you want to explore the upper limit, you can add a 40mM group) Unified pH: Adjust the final pH of all groups to be consistent (such as 7.4) to avoid misjudging pH differences as concentration effects Simultaneous inoculation: Cell density, basic formula of culture medium, and serum batch remain consistent, with 0mM as the control Observation period: Covering your actual cultivation period, such as 5-7 days Monitoring indicators: Daily microscopic observation of morphology and convergence, endpoint quantified by vitality testing (such as CCK-8, MTT, or table blue) Record osmotic pressure: Record the measured osmotic pressure of each group together to distinguish between concentration effect and osmotic pressure effect For sensitive cells such as primary cells and stem cells, it is recommended to start testing at lower concentrations and record the lighting conditions together. 5.Four operational habits to reduce risks The concentration should not exceed 25mM unless there is clear experimental evidence to support higher concentrations The entire process is protected from light, and both the reserve solution and culture medium are stored away from light Recheck the osmotic pressure and measure it once every time the formula is adjusted Selecting cell culture grade raw materials with stricter control over indicators such as endotoxins and heavy metals, resulting in less interference with sensitive cells HEPES' 'low toxicity' is a relative concept, not an unlimited passport. By simultaneously controlling concentration, osmotic pressure, and light exposure, and conducting a gradient validation on one's own cells, most questions about toxicity can be answered clearly. Hubei Xindesheng Material Technology Co., Ltd. provides customized supply methods from conventional models to indicators in the field of biological buffering agents. Customers can propose indicators such as purity, metal ion residue, and UV absorption based on their own experimental systems. The company is headquartered in Guanggu United Science and Technology City, Gedian Development Zone, Ezhou, Hubei Province, with two bases in Gedian and Huanggang. The annual production capacity of all categories is 5000 tons.

1.Why choose Tris when there are so many pH regulators? In the design of industrial ink formulations, the selection of pH regulators may seem simple, but it actually involves balancing multiple technical parameters such as buffering capacity, surface activity, compatibility, and long-term stability. Common pH regulators include ammonia water, triethanolamine (TEA), sodium hydroxide, various Good's buffers, etc. So, what makes Tris buffer stand out as the preferred choice for high-end ink formulations such as inkjet ink and digital printing ink? 2.Tris's molecular structure code: one molecule, two functions The molecular formula of Tris (trihydroxymethylaminomethane) is C ₄ H ₁₁ NO ∝, with a central carbon atom as the core, connecting three hydroxymethyl groups (- CH ₂ OH) and one primary amino group (- NH ₂). This structure endows Tris with a unique dual function: Primary amino (- NH ₂): Provides alkalinity and pH buffering ability, pKa=8.06 (25 ℃), effective buffering range pH 7.0-9.0 Three hydroxymethyl groups (- CH ₂ OH): endow molecules with polarity and surface activity, enabling them to possess both wetting and dispersing functions One molecule plays both the role of pH regulator and surfactant - this is the core reason why Tris is difficult to replace in ink formulations. 3.The Four Major Technical Functions of Tris in Ink 3.1 pH buffering: ensuring long-term stability of ink The pH value of ink directly affects the solubility stability of dyes, the dispersion state of pigments, and the service life of print heads. The effective buffering range of Tris is pH 7.0-9.0-4, which precisely covers the suitable pH range for most industrial inks (usually 6-10). More importantly, the Tris buffer system can continuously maintain pH stability during long-term ink storage - something that volatile bases such as ammonia cannot achieve (ammonia volatilization can cause a continuous decrease in pH). 3.2 Pigment dispersion control: ensuring dispersion effect from the source The synthesis (coupling reaction) stage of pigments is crucial in the production of pigment based inks. Research has shown that when using simple ammonia instead of Tris, appropriate dispersion effects cannot be achieved. The mechanism lies in: The pH will change rapidly during the coupling reaction process Tris, as a pH buffer under alkaline conditions, can inhibit pH mutations Thereby controlling the uniform growth of pigment particles Provide favorable conditions for the adsorption of dispersant polymers on the surface of pigment particles In contrast, Good's buffer with buffering effect in more acidic regions is difficult to achieve appropriate dispersion effect. 3.3 Surface Activity: Improving Wetting and Penetration The three hydroxymethyl groups in Tris molecule give it a certain surface activity. In ink formulations, Tris can: Reduce the surface tension of ink and improve its wettability to printing media Promote the uniform spreading of ink on different media surfaces such as paper, fabric, plastic, etc Improve the clarity and color saturation of printed materials 3.4 Metal ion compatibility: does not interfere with the reaction system Tris does not chelate with common metal ions such as Ca ² ⁺ and Mg ² ⁺, and does not deprive the ink formulation of any metal cofactors that may be required. At the same time, Tris itself does not introduce metal ions such as sodium and potassium, avoiding the problem of metal ion contamination that traditional inorganic bases may cause. 4.Tris vs other pH regulators: Technical parameter comparison Comparison Dimension Tris ammonia water Triethanolamine Sodium hydroxide Buffer Capacity ★★★★★ ★ ★★★ ★ Extremely Low without tall low Nothing surface activity have Nothing have Nothing Introduction of metal ions Nothing Nothing Nothing introduction of Na ⁺ Long term pH stability Excellent Poor good general Recommended addition amount 0.1%-2%- — — —   5.Process suggestions 5.1 Recommended addition amount of Tris According to patent literature, the content of Tris in ink compositions is usually 0.1% to 2% (by mass), preferably 0.3% to 1.5%. The specific amount of addition needs to be determined through experiments based on the initial pH, target pH, and buffering capacity requirements of the ink system. 5.2 Process precautions Dissolving sequence: It is recommended to add Tris in the early stage of ingredient preparation to ensure sufficient dissolution before adding other components PH adjustment: Tris itself is weakly alkaline. If further pH adjustment is needed, it can be used in conjunction with Tris HCl buffer system- Dark storage: Tris buffer is prone to absorbing carbonase-4 from the air, and should be sealed and stored in the dark after preparation Temperature effect: The pKa of Tris varies with temperature (Δ pKa/℃ ≈ -0.031), and pH shift should be noted in high temperature environments Hubei Xindesheng Material Technology Co., Ltd. has been specializing in the research and production of Tris for more than ten years. The product purity is stable at over 99%, with batch differences ≤ 1%, which can meet the consistency and reliability requirements of industrial ink formulations for Tris raw materials. The company has an independent R&D team that can assist customers in formula adaptation and process optimization. We welcome R&D departments of various ink companies to call or write to discuss technical issues.

Industry background: The biological buffer market is entering a period of rapid growth In recent years, with the continuous expansion of the global biopharmaceutical industry, the continuous iteration of in vitro diagnostic (IVD) technology, and the increasing investment in life science research, the market demand for biological buffering agents, as the core chemical raw materials for maintaining pH stability in biological systems, is experiencing unprecedented rapid growth. According to statistics, the market size of China's biological buffer industry has reached 2.357 billion yuan by 2025, a year-on-year increase of 7.97%. With the popularization of molecular diagnosis and immune detection technologies, the demand for high-end biological buffering agents such as HEPES, MOPS, TRIS continues to rise. The rapid development of cutting-edge fields such as cell and gene therapy (CGT) has also opened up new growth opportunities for the biological buffer market. From a global perspective, the bio buffer market also maintains strong growth momentum. According to Marketresearch.biz report, the global market size of biological buffering agents is expected to grow from $754 million in 2022 to $1.859 billion in 2032. Another organization predicts that the global market size of biological buffering agents will exceed 1.09 billion US dollars by 2026, and is expected to exceed 2.18 billion US dollars by 2035. In terms of segmented products, taking New Desheng's core product Tris as an example, the global Tris market is expected to grow from $770 million in 2025 to $950 million in 2026, and expand to $6.89 billion by 2035, with a compound annual growth rate of 24.65% from 2026 to 2035. The use of Tris as a buffering agent in drug formulation, bioprocessing, and molecular biology research continues to increase, and the demand for high-purity products is particularly strong. Another core product, HEPES, also saw significant growth. According to QYResearch, the global HEPES market sales have reached 531 million yuan by 2025, and are expected to climb to 952 million yuan by 2032, with a compound annual growth rate of 8.8%. HEPES is widely used in fields such as cell culture and IVD reagents, and the market demand continues to release. Domestic substitution accelerates, upstream raw material enterprises usher in strategic opportunities It is worth noting that against the backdrop of increasing global geopolitical risks and growing emphasis on supply chain security, the domestic substitution process for biological buffering agents is accelerating comprehensively. As the starting year of the 15th Five Year Plan, 2026 is accelerating the formation of a clear policy system to support domestic scientific research reagents. Beijing, Shanghai, Suzhou, Shenzhen and other places have explicitly included "domestication of biological reagents" in their local biopharmaceutical industry special plans. The 14th Five Year Plan for the Development of Bioeconomy lists buffer solutions as key consumables for research and development, and the country continues to increase support for upstream core raw materials in biomedicine. Under the dual demands of supply chain security and cost reduction and efficiency improvement, domestic biopharmaceutical and IVD enterprises are accelerating the introduction of high-quality local suppliers. The core raw materials upstream of the in vitro diagnostic industry chain, including diagnostic enzymes, antigens/antibodies, biological buffering agents, chemical raw materials, etc., are accelerating the breakthrough of import dependence. New Desheng: Deeply cultivating IVD core raw materials and embracing market opportunities with a full range of product layouts Since its establishment, Hubei Xindesheng Material Technology Co., Ltd. has always focused on the field of IVD reagent raw materials, deeply cultivating the research and development, production, and sales of core products such as blood vessel additives, biological buffering agents, chemiluminescence reagents, colorimetric reagents, enzyme preparations, etc. In the biological buffering agent sector, Xindesheng has formed a matrix of more than 50 products represented by Tris, HEPES, MOPS, Bicine, Caps, Taps, EPPS, PIPES, etc., with a stable purity of over 99%, and can customize indicators according to customer application scenarios. The company's daily production can reach 5 tons, with an annual output of 2000 tons, which can meet the full cycle raw material needs of IVD enterprises from research and development to mass production. In terms of product quality, Xindesheng strictly organizes production according to the ISO 9001 quality management system, with batch differences controlled within 1%. The products are widely used in high-end application scenarios such as in vitro diagnostic kits, cell culture media, and biopharmaceuticals. In addition to biological buffering agents, Xindesheng has also developed a series of chemiluminescence reagents represented by acridine ester and luminol, a series of chromogenic substrates represented by TOOS and MAOS, and a blood sample pretreatment product system represented by heparin lithium, heparin sodium, EDTA dipotassium, tripotassium, and serum separation gel, providing one-stop services from raw materials to solutions for IVD enterprises. With the continuous expansion of the Chinese biological buffer market and the deepening of the domestic substitution process for IVD core raw materials, Xindesheng will continue to leverage its technological advantages in chemical synthesis and large-scale production, continuously optimize product quality, enrich product pipelines, and provide high-purity, high batch consistency, and cost-effective core raw material guarantees for domestic and foreign IVD and biopharmaceutical enterprises. Recent developments of the company can be followed: the orderly promotion of the construction of Huanggang new production base, and the gradual realization of stable mass production of enzyme products such as amylase substrates. Welcome new and old customers and partners to call or write to discuss cooperation.